Medtronic (XSWX:MDT) Inventories, Finished Goods: CHF3,209 Mil (As of Apr. 2026)


XSWX:MDT Medtronic PLC XSWX:MDT
21 GF Score
Price CHF65.29
GF Value CHF80.97
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Medtronic Inventories, Finished Goods?

Medtronic XSWX:MDT +1.21% 21 Inventories, Finished Goods is CHF3,209 Mil as of Apr. 2026. GuruFocus rates XSWX:MDT with a GF Score™ of 21/100 and a GF Value™ of CHF80.97 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Medtronic's quarterly finished goods declined from Oct. 2025 (CHF3,346 Mil) to Jan. 2026 (CHF3,311 Mil) and declined from Jan. 2026 (CHF3,311 Mil) to Apr. 2026 (CHF3,209 Mil).

Medtronic's annual finished goods declined from Apr. 2024 (CHF3,338 Mil) to Apr. 2025 (CHF3,151 Mil) but then increased from Apr. 2025 (CHF3,151 Mil) to Apr. 2026 (CHF3,209 Mil).

Medtronic Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Medtronic's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medtronic Inventories, Finished Goods Chart

Medtronic Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,901.15 3,090.84 3,337.51 3,150.55 3,209.47

Medtronic Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,150.55 3,213.18 3,345.51 3,310.74 3,209.47
XSWX:MDT
21GF Score
Medtronic PLC XSWX:MDT
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medtronic Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of CHF3,209 Mil mean?
Medtronic (XSWX:MDT) has a Inventories, Finished Goods of CHF3,209 Mil as of Apr. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on Medtronic and its competitors.
Is Medtronic's Inventories, Finished Goods too high?
Medtronic's current Inventories, Finished Goods is CHF3,209 Mil. Overall, Medtronic has a GF Score™ of 21/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medtronic's Inventories, Finished Goods compare to SYK and BSX?
Medtronic's Inventories, Finished Goods of CHF3,209 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Medical Devices & Instruments company?
A good Inventories, Finished Goods depends on the Medical Devices & Instruments industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Medtronic and its competitors. Medtronic's current Inventories, Finished Goods is CHF3,209 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medtronic stock overvalued right now?
Based on GuruFocus' analysis, Medtronic (XSWX:MDT) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF80.97, compared to a current price of CHF65.29 — trading 19.4% below its estimated fair value. The current Inventories, Finished Goods is CHF3,209 Mil. Medtronic's overall GF Score™ is 21/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Medtronic (XSWX:MDT), the current Inventories, Finished Goods is CHF3,209 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medtronic (XSWX:MDT) Overvalued in 2026?

Based on GuruFocus' analysis, Medtronic stock appears to be undervalued. The current stock price of CHF65.29 is trading 19.4% below its estimated GF Value™ of CHF80.97. GuruFocus considers Medtronic to be Modestly Undervalued.

Key valuation signals for XSWX:MDT:

  • Inventories, Finished Goods: CHF3,209 Mil
  • GF Value™: CHF80.97 vs. price of CHF65.29 (19.4% below fair value)
  • GF Score™: 21/100 with 3 warning signs

No single metric tells the full story. See the XSWX:MDT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medtronic Business Description

Address Parkmore Business Park West, Building Two, Galway, IRL
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
21GF Score

Get the complete analysis for XSWX:MDT

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF65.29
Price
CHF80.97
GF Value